$TPIV - BE SURE TO CHECK OUT partnership news with AZN TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute http://finance.yahoo.com/news/tapimmune-announces-phase-2-ovarian-131500507.html Plus partnership with Mayo Clinic. All beginning soon. Watch closely.